Surgeon-in-Chief, Ucsf Helen Diller Family Cancer Center, University of California, San Francisco, School of Medicine, 2009 - 2011
Professor in Residence, Surgery, University of California, San Francisco, School of Medicine, 2009 - 2011
Chief, Division Of Breast Surgery Oncology, University of California, San Francisco, School of Medicine, 2008 - 2011
Associate Professor in Residence, Surgery, University of California, San Francisco, School of Medicine, 2004 - 2009
Assistant Professor in Residence, Surgery, University of California, San Francisco, School of Medicine, 1998 - 2004
Senior Reigstrar, General Surgical Oncology, Singapore General Hospital, 1998 - 1999
Fellow, Breast Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1996 - 1997
Resident, General Surgery, Cornell University, 1992 - 1996
Intern, General Surgery, Kaiser Foundation Hospital, 1991 - 1992
M.P.H., University of California at Berkeley, 2006
M.D., University of California at Los Angeles, 1991

In the News

Duke Adds 21 Faculty to Distinguished Faculty RankMay 7, 2019
Tar Heel of the Week: Duke cancer surgeon champions fewer mastectomiesMay 31, 2016
The 100 Most Influential People: Surgery professor Shelley HwangApril 22, 2016
Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016April 22, 2016
Dr. Shelley Hwang: New measure of mastectomyMarch 22, 2016
Double mastectomy may not be the answer for cancer in one breastMarch 18, 2016
Quality of Life Not Notably Better for Women Choosing Double MastectomyMarch 8, 2016
How elective breast cancer surgery affects quality of lifeMarch 8, 2016
Biden seeks input for cancer 'moonshot' at Duke UniversityFebruary 11, 2016
Study Aims to Resolve How To Manage Pre-Cancers of the BreastFebruary 4, 2016
What's the Best Way to Treat Women with Stage 0 Breast Cancer?December 29, 2015
Who can delay breast cancer treatment? A new math model adds cluesDecember 17, 2015
With early breast cancer treatment, less may be more: StudiesDecember 10, 2015
Why Aren't Cancer Death Rates for DCIS Falling?October 9, 2015
Why Doctors Are Rethinking Breast Cancer TreatmentOctober 6, 2015
Study: Chemo unnecessary in many cases of early-stage breast cancerOctober 5, 2015
Dr. Shelley Hwang: Why doctors are rethinking breast-cancer treatmentOctober 1, 2015
Some cancer experts see 'overdiagnosis,' question emphasis on early detectionSeptember 16, 2014
Think pink: Lumpectomy vs. mastectomyOctober 4, 2013

Selected Grants

Publications

Ong, Cecilia, Samantha Thomas, Laura Rosenberger, Tristen Park, Jennifer Plichta, Oluwadamilola Fayanju, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “Patient age and tumor subtype predicts adherence to ACOSOG Z0011 recommendations: Analysis of national practice patterns.” In Annals of Surgical Oncology, 24:164–65. SPRINGER, 2017.

Scholars@Duke

Recht, Abram, Elizabeth A. Comen, Richard E. Fine, Gini F. Fleming, Patricia H. Hardenbergh, Alice Y. Ho, Clifford A. Hudis, et al. “Reply to L.B. Marks et al..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 11 (April 2017): 1258–59. https://doi.org/10.1200/jco.2016.71.3966.

Full Text

Lane, Whitney, Samantha M. Thomas, Jennifer K. Plichta, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Surgical resection of the primary tumor in women with stage IV breast cancer: Contemporary practice patterns and survival analysis.” In Annals of Surgical Oncology, 24:46–46. SPRINGER, 2017.

Scholars@Duke

Park, Tristen, Samantha Thomas, Laura Rosenberger, Oluwadamilola Fayanju, Jennifer Plichta, Cecilia Ong, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “The Impact of Axillary Surgery on Women with N2-N3 Invasive Breast Cancer.” In Annals of Surgical Oncology, 24:162–63. SPRINGER, 2017.

Scholars@Duke

Shelley Hwang, E., and Alastair Thompson. “What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?.” J Natl Cancer Inst 109, no. 4 (April 1, 2017). https://doi.org/10.1093/jnci/djw270.

Full Text

Manders, Jennifer B., Henry M. Kuerer, Benjamin D. Smith, Cornelia McCluskey, William B. Farrar, Thomas G. Frazier, Linna Li, et al. “Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ..” Ann Surg Oncol 24, no. 3 (March 2017): 660–68. https://doi.org/10.1245/s10434-016-5583-7.

Full Text

Fayanju, Oluwadamilola M., and E Shelley Hwang. “Contralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider Recommendations..” Jama Surg 152, no. 3 (March 1, 2017): 282–83. https://doi.org/10.1001/jamasurg.2016.4750.

Full Text

Hwang, E Shelley, and Xiaofei Wang. “Value of Propensity Score Matching to Study Surgical Outcomes..” Ann Surg 265, no. 3 (March 2017): 457–58. https://doi.org/10.1097/SLA.0000000000002125.

Full Text

Burgess, Michael R., Eugene Hwang, Rana Mroue, Craig M. Bielski, Anica M. Wandler, Benjamin J. Huang, Ari J. Firestone, et al. “KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer..” Cell 168, no. 5 (February 23, 2017): 817-829.e15. https://doi.org/10.1016/j.cell.2017.01.020.

Full Text

Ding, Y., J. R. Marks, L. M. King, A. H. Hall, E. R. Mardis, A. G. Rodrigo, C. C. Maley, and E. -. S. Hwang. “Abstract P1-06-06: Evidence for tumor heterogeneity and clonal evolution during invasive progression of breast cancer.” In Poster Session Abstracts. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7445.sabcs16-p1-06-06.

Full Text

You are here

Eun-Sil Shelley Hwang, MD, MPH

Education and Training

In the News

Selected Grants

Publications

Pages